Sutro Biopharma Inc (STRO)
3.42
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
3.425
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Free Cash Flow (Quarterly): 12.63M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 12.63M |
September 30, 2023 | -33.83M |
June 30, 2023 | -32.80M |
March 31, 2023 | -61.93M |
December 31, 2022 | -27.23M |
September 30, 2022 | 65.12M |
June 30, 2022 | -5.386M |
March 31, 2022 | -36.81M |
December 31, 2021 | -24.12M |
September 30, 2021 | -29.40M |
June 30, 2021 | -10.68M |
March 31, 2021 | -32.81M |
Date | Value |
---|---|
December 31, 2020 | -20.50M |
September 30, 2020 | -20.66M |
June 30, 2020 | -14.27M |
March 31, 2020 | -19.50M |
December 31, 2019 | -15.20M |
September 30, 2019 | -16.79M |
June 30, 2019 | -16.09M |
March 31, 2019 | -20.42M |
December 31, 2018 | -6.733M |
September 30, 2018 | 47.21M |
June 30, 2018 | -13.98M |
March 31, 2018 | -15.37M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-61.93M
Minimum
Mar 2023
65.12M
Maximum
Sep 2022
-17.91M
Average
-20.50M
Median
Dec 2020
Free Cash Flow (Quarterly) Benchmarks
Anika Therapeutics Inc | 1.798M |
ABVC BioPharma Inc | -0.4795M |
Reviva Pharmaceuticals Holdings Inc | -8.876M |
Flora Growth Corp | -1.164M |
Journey Medical Corp | -16.52M |